Skip to main content

Advertisement

SpringerLink
Log in

Navigating the Diagnostic Maze: Unraveling the Non-invasive Evaluation of Bladder Outlet Obstruction in Men—a Comprehensive Systematic Review

  • REVIEW
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Bladder outlet obstruction (BOO) encompasses the diagnosis of obstructive urinary flow accompanied by increased detrusor pressure. It can contribute to renal function deterioration, recurrent urinary tract infections, and potentially acute urine retention. While the diagnosis of BOO plays a critical role in clinical management and decision-making, a consensus on the precise evaluation remains elusive. This study aimed to comprehensively review non-invasive methods for diagnosing BOO, primarily in cases related to benign prostatic hyperplasia.

Recent Findings

A systematic literature review was conducted on PubMed from January 2016 to November 2022, focusing on non-invasive tests and lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO) in men. A total of 2520 results were included, resulting in 1620 unique findings after removing duplicates. From these, 263 abstracts were thoroughly evaluated, leading to a detailed review of 80 full-text articles and their references. The review identified numerous cutting-edge technologies, primarily ultrasound-based, such as intravesical prostatic protrusion (IPP), bladder wall thickness (BWT), and detrusor wall thickness (DWT), among others. These advancements demonstrate promising sensitivity and specificity, positioning them as valuable tools for evaluating patients with BOO.

Summary

Achieving an accurate diagnosis and implementing effective management strategies for BOO patients can lead to improved patient care, optimized resource allocation for those in need, and significant reductions in unnecessary expenditures. In the near future, a plethora of additional tools will become available, poised to enhance our diagnostic and prognostic approaches for patients with BOO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms. Urol Clin N Am. 2016;43(3):289–97.

    Article  Google Scholar 

  2. Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in men aged ≥80 years. Urology. 2008;72(2):318–21.

    Article  PubMed  Google Scholar 

  3. Solvang M, Elnegaard S, Jarbøl DE. Urological symptoms among 23,240 men in the general danish population - concerns about symptoms, their persistence and influence on primary care contacts. Scand J Prim Health Care. 2018;36(3):227–36.

    Article  PubMed  PubMed Central  Google Scholar 

  4. D’Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433–77. Include the comprehensive and updated report that defined the subjective and objective pathologies used to this study and their criteria.

    Article  PubMed  Google Scholar 

  5. Taylor BC, Wilt TJ, Fink HA, Lambert LC, Marshall LM, Hoffman AR, et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68(4):804–9.

    Article  PubMed  Google Scholar 

  6. Wong SYS, Hong A, Leung J, Kwok T, Leung PC, Woo J. Lower urinary tract symptoms and depressive symptoms in elderly men. J Affect Disord. 2006;96(1):83–8.

    Article  PubMed  Google Scholar 

  7. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in america project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256–61.

    Article  PubMed  Google Scholar 

  8. Rule AD, Jacobson DJ, Roberts RO, Girman CJ, McGree ME, Lieber MM, et al. The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. Kidney Int. 2005;67(6):2376–82. This is the most comprehensive and updated study to examine the consequences of BOO and LUTS regarding to kidney damage.

    Article  PubMed  Google Scholar 

  9. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158(2):481–7.

    Article  CAS  PubMed  Google Scholar 

  10. Armitage JN, Sibanda N, Cathcart PJ, Emberton M, van der Meulen JHP. Mortality in men admitted to hospital with acute urinary retention: database analysis. BMJ. 2007;335(7631):1199–202.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wadie BS, Ebrahim EHE, Gomha MA. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study. J Urol. 2002;168(1):132–4.

    Article  PubMed  Google Scholar 

  12. Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol. 2008;54(2):419–26.

    Article  PubMed  Google Scholar 

  13. Kang MY, Ku JH, Oh SJ. Non-invasive parameters predicting bladder outlet obstruction in korean men with lower urinary tract symptoms. J Korean Med Sci. 2010;25(2):272–5.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Porru D, Jallous H, Cavalli V, Sallusto F, Rovereto B. Prognostic value of a combination of IPSS, flow rate and residual urine volume compared to pressure-flow studies in the preoperative evaluation of symptomatic BPH. Eur Urol. 2002;41(3):246–9.

    Article  CAS  PubMed  Google Scholar 

  15. Blaivas JG, Forde JC, Davila JL, Policastro L, Tyler M, Aizen J, et al. Surgical treatment of detrusor underactivity: a short term proof of concept study. Int Braz J Urol. 2017;43(3):540–8. This study established the difference in outcomes between DU and BOO, and supports the use of urodynamic findings and their utility in the clinical decision making.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Eckhardt MD, van Venrooij GEPM, Boon TA. Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia. Urology. 2001;58(6):966–71.

    Article  CAS  PubMed  Google Scholar 

  17. EAU guidelines on the management of non-neurogenic male LUTS - diagnostic evaluation - Uroweb [Internet]. Uroweb - European Association of Urology. [cited 2022 Sep 13]. Available from: https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/diagnostic-evaluation. These guidelines include comprehensive review of many aspects and were used as comparison to our review.

  18. Yiou R, Audureau E, Loche CM, Dussaud M, Lingombet O, Binhas M. Comprehensive evaluation of embarrassment and pain associated with invasive urodynamics. Neurourol Urodyn. 2015;34(2):156–60.

    Article  PubMed  Google Scholar 

  19. Ko KJ, Suh YS, Kim TH, Sung HH, Ryu GH, Lee KS. Diagnosing bladder outlet obstruction using the penile cuff test in men with lower urinary tract symptoms. Neurourol Urodyn. 2017;36(7):1884–9. This study demonstrates the utility of penile cuff test compared with PFS, in terms of costs, adverse events, and accuracy.

    Article  PubMed  Google Scholar 

  20. Onur R, Özden M, Orhan I, Kalkan A, Semercioz A. Incidence of bacteraemia after urodynamic study. J Hosp Infect. 2004;57(3):241–4.

    Article  CAS  PubMed  Google Scholar 

  21. Foon R, Toozs‐Hobson P, Latthe P. Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies. Cochrane Database of Systematic Reviews [Internet]. 2012 [cited 2022 Sep 18];(10). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008224.pub2/full.

  22. Porru D, Madeddu G, Campus G, Montisci I, Scarpa RM, Usai E. Evaluation of morbidity of multi-channel pressure-flow studies. Neurourol Urodyn. 1999;18(6):647–52.

    Article  CAS  PubMed  Google Scholar 

  23. Leitner L, Walter M, Sammer U, Knüpfer SC, Mehnert U, Kessler TM. Urodynamic investigation: a valid tool to define normal lower urinary tract function? PLoS ONE. 2016;11(10): e0163847.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Nr S, Je S, Ap K. Artifacts and abnormal findings may limit the use of asymptomatic volunteers as controls for studies of multichannel urodynamics. Minerva urology and nephrology [Internet]. 2021 Oct [cited 2022 Dec 2];73(5). Available from: https://pubmed.ncbi.nlm.nih.gov/32638575/.

  25. Nitti VW, Kim Y, Combs AJ. Correlation of the AUA symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn. 1994;13(5):521–7 (discussion 527-529).

    Article  CAS  PubMed  Google Scholar 

  26. de la Rosette JJMCH, Witjes WPJ, Schäfer W, Abrams P, Donovan JL, Peters TJ, et al. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-“BPH” study. Neurourol Urodyn. 1998;17(2):99–108.

    Article  PubMed  Google Scholar 

  27. Reddy SVK, Shaik AB. Non-invasive evaluation of bladder outlet obstruction in benign prostatic hyperplasia: a clinical correlation study. Arab J Urol. 2019;17(4):259–64. This study gave a recent view of the accuracy of few tests to diagnose BOO.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Steele GS, Sullivan MP, Sleep DJ, Yalla SV. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms. J Urol. 2000;164(2):344–8.

    Article  CAS  PubMed  Google Scholar 

  29. Hashim H, Elhilali M, Bjerklund Johansen TE, Abrams P. The immediate and 6-mo reproducibility of pressure–flow studies in men with benign prostatic enlargement. Eur Urol. 2007;52(4):1186–94.

    Article  PubMed  Google Scholar 

  30. Renganathan A, Cartwright R, Cardozo L, Robinson D, Srikrishna S. Quality control in urodynamics: analysis of an international multi-center study. Neurourol Urodyn. 2009;28(5):380–4.

    Article  PubMed  Google Scholar 

  31. XLewis AL, Young GJ, Selman LE, Rice C, Clement C, Ochieng CA, et al. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT. Health Technol Assess. 2020;24(42):1–122. This comprehensive and important study re-opens the discussion about the use and utility of PFS – which may have far-reaching consequences on this issue.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management. J Urol. 2021;206(4):806–17. These guidelines include comprehensive review of many aspects and were used as comparison to our review.

    Article  PubMed  Google Scholar 

  33. Arnolds M, Oelke M. Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction. Curr Opin Urol. 2009;19(1):55–62.

    Article  PubMed  Google Scholar 

  34. Jung JH, Cho SY, Yoo C, Oh SJ. Establishment of the novel cystoscopic classification for bladder trabeculation of neurogenic bladder. Urology. 2014;84(3):515–9.

    Article  PubMed  Google Scholar 

  35. Takahashi R, Takei M, Namitome R, Yamaguchi O, Eto M. Symptoms and noninvasive test parameters that clinically differentiate detrusor underactivity from bladder outlet obstruction without a pressure-flow-based diagnosis in men with lower urinary tract symptoms. Neurourol Urodyn. 2021;40(1):303–9. This big study includes the predictive value of many parameters and non-invasive tests to differentiate between DU and BOO. This can be used in clinical practice.

    Article  PubMed  Google Scholar 

  36. De Nunzio C, Autorino R, Bachmann A, Briganti A, Carter S, Chun F, et al. The diagnosis of benign prostatic obstruction: development of a clinical nomogram. Neurourol Urodyn. 2016;35(2):235–40.

    Article  PubMed  Google Scholar 

  37. Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol. 1999;162(2):376–82.

    Article  CAS  PubMed  Google Scholar 

  38. Emberton M, Elhilali M, Matzkin H, Harving N, van Moorselaar J, Hartung R, et al. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily. Urology. 2005;66(2):316–22.

    Article  PubMed  Google Scholar 

  39. Luciani LG, Mattevi D, Ravanelli D, Anceschi U, Giusti G, Cai T, et al. A novel nomogram based on initial features to predict BPH progression. Int J Environ Res Public Health. 2022;19(15):9738.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Shinbo H, Kurita Y, Nakanishi T, Imanishi T, Otsuka A, Furuse H, et al. Resistive index: a newly identified predictor of outcome of transurethral prostatectomy in patients with benign prostatic hyperplasia. Urology. 2010;75(1):143–7.

    Article  PubMed  Google Scholar 

  41. Vredeveld T, van Benten E, Beekmans REPM, Koops MP, Ket JCF, Mollema J, et al. Reliability and validity of assessment methods available in primary care for bladder outlet obstruction and benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review. BMJ Open. 2022;12(4): e056234. This comprehensive and recent systematic review provides valuable data about the validity and reliability of different parameters, including differences between different ways of achieving them.

    Article  PubMed  PubMed Central  Google Scholar 

  42. de la Cruz MB, Adot Zurbano JM, Gutiérrez-Mínguez E, Gómez Sánchez E, Calvo S, Tamayo GE. Development of a Predictive model for the diagnosis of lower urinary tract obstruction in men. J Urol. 2022;208(3):668–75. This big study made a validated prediction model to differentiate between DU and BOO, based on multivariable analysis made of few easy-to-take parameters.

    Article  Google Scholar 

  43. Lee YJ, Lee JK, Kim JJ, Lee HM, Oh JJ, Lee S, et al. Development and validation of a clinical nomogram predicting bladder outlet obstruction via routine clinical parameters in men with refractory nonneurogenic lower urinary tract symptoms. Asian J Androl. 2019;21(5):486–92. This study provides nomogram and information about the predictive value of many parameters.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Roehrborn CG, Sech S, Montoya J, Rhodes T, Girman CJ. Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination. Urology. 2001;57(6):1087–92.

    Article  CAS  PubMed  Google Scholar 

  45. Stone BV, Shoag J, Halpern JA, Mittal S, Lewicki P, Golombos DM, et al. Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men. BJU Int. 2017;119(2):298–304.

    Article  CAS  PubMed  Google Scholar 

  46. Loeb S, Han M, Roehl KA, Antenor JAV, Catalona WJ. Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography. J Urol. 2005;173(1):63–5.

    Article  PubMed  Google Scholar 

  47. Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM, et al. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology. 1997;49(4):548–57.

    Article  CAS  PubMed  Google Scholar 

  48. Roehrborn CG, Chinn HKW, Fulgham PF, Simpkins KL, Peters PC. The role of transabdominal ultrasound in the prostatic hypertrophy. J Urol. 1986;135(6):1190–3.

    Article  CAS  PubMed  Google Scholar 

  49. Bosch JLHR, Bohnen AM, Groeneveld FPMJ. Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: The Krimpen Study. Eur Urol. 2004;46(6):753–9.

    Article  CAS  PubMed  Google Scholar 

  50. Su MZ, Lenaghan D, Woo HH. Dichotomous estimation of prostate volume: a diagnostic study of the accuracy of the digital rectal examination. World J Mens Health. 2013;31(3):220–5. This study is the biggest and latest information about the use of digital rectal examination and provides a method to use it properly.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Oelke M, Höfner K, Jonas U, de la Rosette JJ, Ubbink DT, Wijkstra H. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol. 2007;52(3):827–35.

    Article  PubMed  Google Scholar 

  52. Reynard JM, Yang Q, Donovan JL, Peters TJ, Schafer W, de la Rosette JJ, et al. The ICS-’BPH’ study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol. 1998;82(5):619–23.

    Article  CAS  PubMed  Google Scholar 

  53. Wadie BS. How correlated is BOO with different objective parameters commonly used in evaluation of BPH: a prospective study. Int Urol Nephrol. 2021;53(4):635–40. This study examined the correlation (not the predictive value and cutoffs) of the objective parameters commonly used- and showed their limited association with symptoms and obstruction scores.

    Article  CAS  PubMed  Google Scholar 

  54. Cheng Y, Li T, Wu X, Ling Q, Rao K, Yuan X, et al. The diagnostic value of non-invasive methods for diagnosing bladder outlet obstruction in men with lower urinary tract symptoms: a meta-analysis. Front Surg [Internet]. 2022 [cited 2022 Nov 13];9. Available from: https://www.frontiersin.org/articles/10.3389/fsurg.2022.986679. This is the most recent and largest meta-analysis we found that examines the predictive values of many parameters.

  55. Nitti VW. Pressure Flow Urodynamic Studies: The gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005;7(Suppl 6):S14-21.

    PubMed  PubMed Central  Google Scholar 

  56. Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol. 1979;51(2):129–34.

    Article  CAS  PubMed  Google Scholar 

  57. Zhang X, Li G, Wei X, Mo X, Hu L, Zha Y, et al. Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia. J Urol. 2012;188(3):881–7.

    Article  PubMed  Google Scholar 

  58. Malde S, Nambiar AK, Umbach R, Lam TB, Bach T, Bachmann A, et al. Systematic review of the performance of noninvasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms. Eur Urol. 2017;71(3):391–402. This is an important systematic review and meta-analysis that reviews the properties of the non-invasive tests and their accuracy to predict BOO.

    Article  PubMed  Google Scholar 

  59. Oranusi CK, Nwofor AE, Mbonu O. Correlation between international prostate symptom score and uroflowmetry in patients with benign prostatic hyperplasia. Niger J Clin Pract. 2017;20(4):454–8.

    Article  CAS  PubMed  Google Scholar 

  60. Garg A, Bansal S, Saha S, Kumar A. Study of correlation of urodynamic profile with symptom scoring and ultrasonographic parameters in patients with benign prostatic hyperplasia. J Family Med Prim Care. 2020;9(1):215–20.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Simon RM, Howard LE, Moreira DM, Roehrborn C, Vidal A, Castro-Santamaria R, et al. Does peak urine flow rate predict the development of incident lower urinary tract symptoms in men with mild to no current symptoms? Results from REDUCE. J Urol. 2017;198(3):650–6.

    Article  PubMed  Google Scholar 

  62. Chen X, Man Q, Wei X, Ren X, Li G, Lu Z, et al. Predictive value of preoperative comprehensive evaluation on the efficacy of HoLEP. Transl Androl Urol. 2020;9(4):1603–10. This study provides us a view about the prognostic predictive value of non-invasive tests in the context of HOLEP procedure and not only in the context of BOO diagnosis.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Gravas S, Palacios-Moreno JM, Thompson D, Concas F, Kamola PJ, Roehrborn CG, et al. Understanding treatment response in individual profiles of men with prostatic enlargement at risk of progression. Eur Urol Focus [Internet]. 2022 Aug 18 [cited 2022 Oct 7]; Available from: https://www.sciencedirect.com/science/article/pii/S2405456922001651. This huge data analysis provides us a comprehensive view about the prognostic predictive value of non-invasive tests in the context of pharmacological treatment and not only in the context of BOO diagnosis. This can aid to guide the decision making and enhance the treatment outcomes.

  64. Kim BS, Ko YH, Song PH, Kim TH, Kim KH, Kim BH. Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study. Prostate Int. 2019;7(1):30–4.

    Article  PubMed  Google Scholar 

  65. Namitome R, Takei M, Takahashi R, Kikutake C, Yokomizo A, Yamaguchi O, et al. A prediction model of detrusor underactivity based on symptoms and noninvasive test parameters in men with lower urinary tract symptoms: an analysis of a large group of patients undergoing pressure-flow studies. J Urol. 2020;203(4):779–85. This big study made a prediction model to differentiate between DU and BOO, based on few parameters.

    Article  PubMed  Google Scholar 

  66. Jiang YH, Kuo HC. Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men - a comparison of men with normal tracing and bladder outlet obstruction. PLoS ONE. 2017;12(4): e0174593.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Matsukawa Y, Yoshida M, Yamaguchi O, Takai S, Majima T, Funahashi Y, et al. Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms. Int J Urol. 2020;27(1):47–52.

    Article  PubMed  Google Scholar 

  68. Wada N, Watanabe M, Ishikawa M, Takeuchi K, Miyauchi K, Abe N, et al. Uroflowmetry pattern in detrusor underactivity and bladder outlet obstruction in male patients with lower urinary tract symptoms. LUTS. 2021;13(3):361–5.

    Article  PubMed  Google Scholar 

  69. Yoldas M. Non-invasive diagnosis of under active bladder: a pilot study. Arch Ital Urol Androl. 2022;94(1):51–6.

    Article  PubMed  Google Scholar 

  70. Lambert E, Denys MA, Poelaert F, Everaert K, Lumen N. Validated uroflowmetry-based predictive model for the primary diagnosis of urethral stricture disease in men. Int J Urol. 2018;25(9):792–8.

    Article  PubMed  Google Scholar 

  71. Bray A, Harding C, Pickard R, Drinnan M. Individualized volume-corrected maximum flow rate correlates with outcome from bladder outlet surgery in men with lower urinary tract symptoms. Int J Urol. 2016;23(7):587–92.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Non-neurogenic chronic urinary retention: consensus definition, management strategies, and future opportunities - American Urological Association [Internet]. [cited 2023 May 28]. Available from: https://www.auanet.org/guidelines-and-quality/quality-and-measurement/quality-improvement/clinical-consensus-statement-and-quality-improvement-issue-brief-(ccs-and-qiib)/chronic-urinary-retention. This consensus is important to understand the definition, diagnosis and management of chronic urinary retention and the use of PVR test.

  73. Lee KS, Song PH, Ko YH. Does uroflowmetry parameter facilitate discrimination between detrusor underactivity and bladder outlet obstruction? Investig Clin Urol. 2016;57(6):437–41.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Kalil J, D Ancona CAL. Detrusor underactivity versus bladder outlet obstruction clinical and urodynamic factors. Int Braz J Urol. 2020;46(3):419–24.

    Article  PubMed  PubMed Central  Google Scholar 

  75. • Choo MS, Yoo C, Cho SY, Jeong SJ, Jeong CW, Ku JH, et al. Development of decision support formulas for the prediction of bladder outlet obstruction and prostatic surgery in patients with lower urinary tract symptom/benign prostatic hyperplasia: Part I, Development of the Formula and its Internal Validation. Int Neurourol J. 2017;21(Suppl 1):S55-65. This is a big innovative study that recruits the different common tests to predict (and maybe guide) the decision about surgery, in addition to prediction of BOO.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Töz E, Kurt S, Sahin Ç, Canda MT. Frequency of recurrent urinary tract infection in patients with pelvic organ prolapse. Res Rep Urol. 2015;7:9–12.

    PubMed  PubMed Central  Google Scholar 

  77. Roehrborn CG, Group AS. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study. BJU Int. 2006;97(4):734–41.

    Article  CAS  PubMed  Google Scholar 

  78. Shinbo H, Kurita Y, Takada S, Imanishi T, Otsuka A, Furuse H, et al. Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia. Urology. 2010;76(6):1440–5.

    Article  PubMed  Google Scholar 

  79. Roehrborn CG, Kaplan SA, Lee MW, Slawin KM, McVary KT, Kusek JW, et al. 1638: Baseline post void residual urine volume as a predictor of urinary outcomes in men with BPH in the MTOPS study. J Urol. 2005;173(4S):443–4.

    Article  Google Scholar 

  80. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 1995;154(2 Pt 1):407–13.

    Article  CAS  PubMed  Google Scholar 

  81. Lokant MT, Naz RK. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis). Andrologia. 2015;47(3):328–32.

    Article  CAS  PubMed  Google Scholar 

  82. Zackrisson B, Ulleryd P, Aus G, Lilja H, Sandberg T, Hugosson J. Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection. Urology. 2003;62(2):278–81.

    Article  PubMed  Google Scholar 

  83. Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology. 1999;53(3):581–9.

    Article  CAS  PubMed  Google Scholar 

  84. Morote J, Encabo G, López M, de Torres IM. Prediction of prostate volume based on total and free serum prostate–specific antigen: is it reliable? EUR. 2000;38(1):91–5.

    CAS  Google Scholar 

  85. Patel DN, Feng T, Simon RM, Howard LE, Vidal AC, Moreira DM, et al. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study. Prostate Cancer Prostatic Dis. 2018;21(2):238–44.

    Article  PubMed  Google Scholar 

  86. Roehrborn CG, McConnell J, Bonilla J, Rosenblatt S, Hudson PB, Malek GH, et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol. 2000;163(1):13–20.

    Article  CAS  PubMed  Google Scholar 

  87. Kok ET, Schouten BW, Bohnen AM, Groeneveld FPMW, Thomas S, Bosch JLHR. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen study. J Urol. 2009;181(2):710–6.

    Article  PubMed  Google Scholar 

  88. Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia11A complete list of the members of the PLESS Study Group is given in the Appendix. Urology. 1999;53(3):473–80.

    Article  CAS  PubMed  Google Scholar 

  89. Milonas D, Trumbeckas D. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia. Medicina (Kaunas). 2003;39(11):1071–7.

    PubMed  Google Scholar 

  90. Roehrborn CG, Boyle P, Bergner D, Gray T, Gittelman M, Shown T, et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. Urology. 1999;54(4):662–9.

    Article  CAS  PubMed  Google Scholar 

  91. Wei JT, Barocas D, Carlsson S, Coakley F, Eggener S, Etzioni R, et al. Early detection of prostate cancer: AUA/SUO guideline part i: prostate cancer screening. J Urol. 2023;0(0). https://doi.org/10.1097/JU.0000000000003491.

  92. Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;5(362): k3519.

    Article  Google Scholar 

  93. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(18):1901–13.

    Article  Google Scholar 

  94. Styles RA, Neal DE, Griffiths CJ, Ramsden PD. Long-term monitoring of bladder pressure in chronic retention of urine: the relationship between detrusor activity and upper tract dilatation. J Urol. 1988;140(2):330–4.

    Article  CAS  PubMed  Google Scholar 

  95. George NJ, O’Reilly PH, Barnard RJ, Blacklock NJ. High pressure chronic retention. Br Med J (Clin Res Ed). 1983;286(6380):1780–3.

    Article  CAS  PubMed  Google Scholar 

  96. Lee DS, Kim HW, Lee SJ. Transurethral prostate surgery as a preventive method against progression of chronic kidney disease in patients with urodynamically proven bladder outlet obstruction. World J Urol. 2020;38(10):2583–93.

    Article  PubMed  Google Scholar 

  97. Comiter CV, Sullivan MP, Schacterle RS, Cohen LH, Valla SV. Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction. J Urol. 1997;158(1):181–5.

    Article  CAS  PubMed  Google Scholar 

  98. • Lowe FC, Michel MC, Wruck JM, Verbeek AE. Is dipstick urinalysis screening beneficial in men with lower urinary tract symptoms? Adv Ther. 2019;36(10):2954–67. This huge study shines light on the information that dipstick urinalysis can provide us to diagnose clinically important pathologies.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Khasriya R, Khan S, Lunawat R, Bishara S, Bignal J, Malone-Lee M, et al. The inadequacy of urinary dipstick and microscopy as surrogate markers of urinary tract infection in urological outpatients with lower urinary tract symptoms without acute frequency and dysuria. Journal of Urology. 2010;183(5):1843–7.

    Article  PubMed  Google Scholar 

  100. Doolin J, Reese ZA, Mukamal KJ. National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men. World J Urol. 2021;39(3):855–60.

    Article  PubMed  Google Scholar 

  101. Grossfeld GD, Coakley FV. Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging. Radiol Clin N Am. 2000;38(1):31–47.

    Article  CAS  PubMed  Google Scholar 

  102. Stravodimos KG, Petrolekas A, Kapetanakis T, Vourekas S, Koritsiadis G, Adamakis I, et al. TRUS versus transabdominal ultrasound as a predictor of enucleated adenoma weight in patients with BPH. Int Urol Nephrol. 2009;41(4):767–71.

    Article  PubMed  Google Scholar 

  103. Jia G, Baudendistel KT, von Tengg-Kobligk H, Heverhagen JT, Polzer H, Henry H, et al. Assessing prostate volume by magnetic resonance imaging: a comparison of different measurement approaches for organ volume analysis. Invest Radiol. 2005;40(4):243–8.

    Article  PubMed  Google Scholar 

  104. Rahmouni A, Yang A, Tempany CMC, Frenkel T, Epstein J, Walsh P, et al. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr. 1992;16(6):935–40.

    Article  CAS  PubMed  Google Scholar 

  105. • Garg G, Sankhwar SN, Goel A, Pandey S, Sharma D, Parihar A. Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Low Urin Tract Symptoms. 2019;11(3):163–8. This study provides us with valuable data about the predictive value of different parameters to diagnose BOO.

    Article  PubMed  Google Scholar 

  106. Abdel-Aal A, El-Karamany T, Al-Adl AM, Abdel-Wahab O, Farouk H. Assessment of noninvasive predictors of bladder outlet obstruction and acute urinary retention secondary to benign prostatic enlargement. Arab J Urol. 2011;9(3):209–14.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Lim KB, Ho H, Foo KT, Wong MYC, Fook-Chong S. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int J Urol. 2006;13(12):1509–13.

    Article  PubMed  Google Scholar 

  108. Franco G, De Nunzio C, Leonardo C, Tubaro A, Ciccariello M, De Dominicis C, et al. Ultrasound assessment of intravesical prostatic protrusion and detrusor wall thickness–new standards for noninvasive bladder outlet obstruction diagnosis? J Urol. 2010;183(6):2270–4.

    Article  PubMed  Google Scholar 

  109. Deebajah M, Bazzi M, Walton E, Pantelic M, Park H, Dabaja A, et al. Prostate volume measured by magnetic resonance imaging is not a predictor of lower urinary tract symptoms. J Family Med Prim Care. 2019;8(4):1370–3.

    Article  PubMed  PubMed Central  Google Scholar 

  110. • Yang TK, Chang CC, Chang HC, Yang HJ, Huang KH. Factors associated with bothersome lower urinary tract symptoms in middle-aged men receiving health checkup. Sci Rep. 2019;9(1):901. This study shed light on the association between symptoms and different parameters.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Gyasi-Sarpong CK, Acheampong E, Yeboah FA, Aboah K, Laing EF, Amoah G. Predictors of the international prostate symptoms scores for patients with lower urinary tract symptoms: a descriptive cross-sectional study. Urol Ann. 2018;10(3):317–23.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Barry MJ, Cockett ATK, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 1993;150(2 Part 1):351–8.

    Article  CAS  PubMed  Google Scholar 

  113. • Qian S, Zhang S, Xia W, Xu D, Qi J, Shen H, et al. Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: results from a cross-sectional study. Prostate. 2021;81(8):478–86. This study aims to find the association between different parameters and disease progression, and not only obstruction. This can guide informed decisions to a patient.

    Article  PubMed  Google Scholar 

  114. Boyle P, Lawrence Gould A, Roehrborn CG. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. Urology. 1996;48(3):398–405.

    Article  CAS  PubMed  Google Scholar 

  115. • Hashimoto M, Shimizu N, Sugimoto K, Hongoh S, Minami T, Nozawa M, et al. Efficacy of Adding dutasteride to α-blocker therapy treated benign prostatic hyperplasia patients with small volume prostate (<30 mL). LUTS. 2017;9(3):157–60. This study provided us with valuable data about the significance of prostate size in the context of pharmacological treatment and thus the value of this test regardless of its use to diagnose BOO. The results of studies as such- influenced the current AUA guidelines.

    Article  CAS  PubMed  Google Scholar 

  116. Marks LS, Roehrborn CG, Wolford E, Wilson TH. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response. J Urol. 2007;177(4):1408–13.

    Article  CAS  PubMed  Google Scholar 

  117. Hong SJ, Ko WJ, Kim SI, Chung BH. Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study. Eur Urol. 2003;44(1):94–100.

    Article  PubMed  Google Scholar 

  118. Hong KP, Byun YJ, Yoon H, Park YY, Chung WS. Prospective factor analysis of alpha blocker monotherapy failure in benign prostatic hyperplasia. Korean J Urol. 2010;51(7):488–91.

    Article  PubMed  PubMed Central  Google Scholar 

  119. • Matsukawa Y, Ishida S, Majima T, Funahashi Y, Sassa N, Kato M, et al. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms. Int J Urol. 2017;24(6):454–9. This study provided us valuable data about the significance of different parameters (especially IPP) in context of pharmacological treatment and thus the value of this test regardless of its use to diagnose BOO.

    Article  CAS  PubMed  Google Scholar 

  120. Kalkanli A, Tandogdu Z, Aydin M, Karaca AS, Hazar AI, Balci MBC, et al. Intravesical prostatic protrusion: a potential marker of alpha-blocker treatment success in patients with benign prostatic enlargement. Urology. 2016;1(88):161–5.

    Article  Google Scholar 

  121. Moore RA. Benign hypertrophy and carcinoma of the prostate: occurrence and experimental production in animals. Surgery. 1944;16(1):152–67.

    Google Scholar 

  122. Meikle AW, Stephenson RA, Lewis CM, Middleton RG. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins*. J Clin Endocrinol Metab. 1997;82(2):571–5.

    CAS  PubMed  Google Scholar 

  123. Berges R, Oelke M. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older. World J Urol. 2011;29(2):171–8.

    Article  PubMed  Google Scholar 

  124. Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003;91(4):371–4.

    Article  CAS  PubMed  Google Scholar 

  125. • Lee A, Lee HJ, Lim KB, Huang HH, Ho H, Foo KT. Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow? Asian J Urol. 2016;3(1):39–43. This study gave us a new concept about the ability of non-invasive tests (IPP) to adjunct prediction of BOO even in men with good urinary flow.

    Article  PubMed  Google Scholar 

  126. Keqin Z, Zhishun X, Jing Z, Haixin W, Dongqing Z, Benkang S. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement. Urology. 2007;70(6):1096–9.

    Article  PubMed  Google Scholar 

  127. Krivoborodov GG, Efremov NS, Bolotov AD. Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia. Urologiia. 2017;5:9–14.

    Article  Google Scholar 

  128. Park SC, Lee JW, Rim JS. Relación entre la protrusión prostática intravesical y los hallazgos del estudio de presión-flujo en pacientes con obstrucción prostática benigna/síntomas del tracto urinario inferior. Actas Urológicas Españolas. 2012;36(3):165–70.

    Article  CAS  PubMed  Google Scholar 

  129. Aganovic D, Hasanbegovic M, Prcic A, Kulovac B, Hadziosmanovic O. Which is a better indicator of bladder outlet obstruction in patients with benign prostatic enlargement–intravesical protrusion of prostate or bladder wall thickness? Med Arch. 2012;66(5):324–8.

    Article  PubMed  Google Scholar 

  130. Ahmed AF. Sonographic parameters predicting the outcome of patients with lower urinary tract symptoms/benign prostatic hyperplasia treated with alpha1-adrenoreceptor antagonist. Urology. 2016;88:143–8.

    Article  PubMed  Google Scholar 

  131. Shin SH, Kim JW, Kim JW, Oh MM, Moon DG. Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction. Korean J Urol. 2013;54(6):369–72.

    Article  PubMed  PubMed Central  Google Scholar 

  132. • Tan YG, Teo JS, Kuo TLC, Guo L, Shi L, Shutchaidat V, et al. A systemic review and meta-analysis of transabdominal intravesical prostatic protrusion assessment in determining bladder outlet obstruction and unsuccessful trial without catheter. Eur Urol Focus. 2022;8(4):1003–14. This comprehensive systematic review gave valuable data about trans-abdominal IPP test.

    Article  PubMed  Google Scholar 

  133. Rieken M, Presicce F, Autorino R, De Nunzio C. Clinical significance of intravesical prostatic protrusion in the management of benign prostatic enlargement: a systematic review and critical analysis of current evidence. Minerva Urol Nephrol [Internet]. 2017 Oct [cited 2022 Sep 14];69(6). Available from: https://www.minervamedica.it/index2.php?show=R19Y2017N06A0548.

  134. Raphael JE, Abhulimen V. Is there any relationship between total prostate volume, intravesical prostatic protrusion and lower urinary tract symptoms in adult Nigerian men with benign prostatic enlargement? West Afr J Med. 2021;38(6):578–82.

    CAS  PubMed  Google Scholar 

  135. Eze BU, Mbaeri TU, Oranusi KC, Abiahu JA, Nwofor AM, Orakwe JC, et al. Correlation between intravesical prostatic protrusion and international prostate symptom score among Nigerian men with benign prostatic hyperplasia. Niger J Clin Pract. 2019;22(4):454.

    Article  CAS  PubMed  Google Scholar 

  136. Bang WJ, Kim HW, Lee JY, Lee DH, Hah YS, Lee HH, et al. Prostatic urethral angulation associated with urinary flow rate and urinary symptom scores in men with lower urinary tract symptoms. Urology. 2012;80(6):1333–7.

    Article  PubMed  Google Scholar 

  137. Park YJ, Bae KH, Jin BS, Jung HJ, Park JS. Is increased prostatic urethral angle related to lower urinary tract symptoms in males with benign prostatic hyperplasia/lower urinary tract symptoms? Korean J Urol. 2012;53(6):410–3.

    Article  PubMed  PubMed Central  Google Scholar 

  138. Cumpanas AA, Botoca M, Minciu R, Bucuras V. Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction Treated With Tamsulosin. Urology. 2013;81(4):859–63.

    Article  PubMed  Google Scholar 

  139. • Topazio L, Perugia C, De Nunzio C, et al. Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study. BMC Urol 2018;18:6. https://doi.org/10.1186/s12894-018-0320-0. This study provides us data about the clinically significance of IPP in the meaning of therapeutic response.

  140. Park HY, Lee JY, Park SY, Lee SW, Kim YT, Choi HY, et al. Efficacy of alpha blocker treatment according to the degree of intravesical prostatic protrusion detected by transrectal ultrasonography in patients with benign prostatic hyperplasia. Korean J Urol. 2012;53(2):92–7.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Seo YM, Kim HJ. Impact of intravesical protrusion of the prostate in the treatment of lower urinary tract symptoms/benign prostatic hyperplasia of moderate size by alpha receptor antagonist. Int Neurourol J. 2012;16(4):187–90.

    Article  PubMed  PubMed Central  Google Scholar 

  142. • Matsukawa Y, Kato M, Funahashi Y, Majima T, Yamamoto T, Gotoh M. What are the predicting factors for the therapeutic effects of dutasteride in male patients with lower urinary tract symptoms? Investigation using a urodynamic study. Neurourol Urodyn. 2017;36(7):1809–15. This study reveals the predictive tests for therapeutic effects of dutasteride in male patients with lower urinary tract symptoms.

    Article  CAS  PubMed  Google Scholar 

  143. Hirayama K, Masui K, Hamada A, Shichiri Y, Masuzawa N, Hamada S. Evaluation of intravesical prostatic protrusion as a predictor of dutasteride-resistant lower urinary tract symptoms/benign prostatic enlargement with a high likelihood of surgical intervention. Urology. 2015;86(3):565–9.

    Article  PubMed  Google Scholar 

  144. Mariappan P, Brown DJG, McNeill AS. Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study. J Urol. 2007;178(2):573–7 (discussion 577).

    Article  PubMed  Google Scholar 

  145. Foo KT, Tan YH. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J Urol. 2003;170(6 Pt 1):2339–41.

    PubMed  Google Scholar 

  146. Lee LS, Sim HG, Lim KB, Wang D, Foo KT. Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. Int J Urol. 2010;17(1):69–74.

    Article  PubMed  Google Scholar 

  147. • Tian Y, Zhang H, Cao Y, Yang L, Luo G. The P.R.OS.T.A.T.E nomogram for the preoperative prediction of clinical efficacy of transurethral resection of the prostate in benign prostatic hyperplasia patients. Clin Interv Aging. 2022;17:845–55. This study provided us data about the preoperative parameters that can predict the outcome of TURP and made a nomogram for them.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Rademakers KLJ, van Koeveringe GA, Oelke M. FORCE Research Group, Maastricht and Hannover. Ultrasound detrusor wall thickness measurement in combination with bladder capacity can safely detect detrusor underactivity in adult men. World J Urol. 2017;35(1):153–9.

    Article  PubMed  Google Scholar 

  149. Manieri C, Carter SS, Romano G, Trucchi A, Valenti M, Tubaro A. The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol. 1998;159(3):761–5.

    Article  CAS  PubMed  Google Scholar 

  150. Ding Z, Wang H, Zhang W, et al. Bladder wall thickness measured by CT can predict bladder outlet obstruction in men: a retrospective cohort study. Int Urol Nephrol. 2023;55:43–9. https://doi.org/10.1007/s11255-022-03361-8.

    Article  CAS  PubMed  Google Scholar 

  151. Farag F, Elbadry M, Saber M, Badawy AA, Heesakkers J. A novel algorithm for the non-invasive detection of bladder outlet obstruction in men with lower urinary tract symptoms. Arab J Urol. 2017;15(2):153–8.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Salah Azab S, Elsheikh MG. The impact of the bladder wall thickness on the outcome of the medical treatment using alpha-blocker of BPH patients with LUTS. Aging Male. 2015;18(2):89–92.

    Article  CAS  PubMed  Google Scholar 

  153. Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. I. Methods of a prospective ultrastructural/urodynamic study and an overview of the findings. J Urol. 1993;150(5 Pt 2):1650–6.

    Article  CAS  PubMed  Google Scholar 

  154. Inui E, Ochiai A, Naya Y, Ukimura O, Kojima M. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls. J Urol. 1999;161(3):827–30.

    Article  CAS  PubMed  Google Scholar 

  155. Oelke M, Höfner K, Wiese B, Grünewald V, Jonas U. Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World J Urol. 2002;19(6):443–52.

    Article  PubMed  Google Scholar 

  156. Kessler TM, Gerber R, Burkhard FC, Studer UE, Danuser H. Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study? J Urol. 2006;175(6):2170–3.

    Article  PubMed  Google Scholar 

  157. Sinha S, Matai L. Is isolated bladder outlet obstruction associated with hydronephrosis? A database analysis. Neurourol Urodyn. 2020;39(8):2361–7.

    Article  PubMed  Google Scholar 

  158. van der Waart TH, Boender H, van de Beek C, Wolfs GG, Janknegt RA, Knottnerus JA. Utility of ultrasound of the upper urinary tract in elderly men with indicators of obstructive symptoms or abnormal flow: how often can silent hydronephrosis be detected in general practice? Fam Pract. 1998;15(6):534–6.

    Article  PubMed  Google Scholar 

  159. Koch WF, Ezz el Din K, de Wildt MJ, Debruyne FM, de la Rosette JJ. The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J Urol. 1996;155(1):186–9.

    Article  CAS  PubMed  Google Scholar 

  160. Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. AUA white paper on nonneurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome end points. J Urol. 2017;198(1):153–60.

    Article  PubMed  Google Scholar 

  161. Kojima M, Inui E, Ochiai A, Naya Y, Ukimura O, Watanabe H. Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: a preliminary report. Urology. 1996;47(6):942–7.

    Article  CAS  PubMed  Google Scholar 

  162. Ochiai A, Kojima M. Correlation of ultrasound-estimated bladder weight with ultrasound appearance of the prostate and postvoid residual urine in men with lower urinary tract symptoms. Urology. 1998;51(5):722–9.

    Article  CAS  PubMed  Google Scholar 

  163. Kojima M, Inui E, Ochiai A, Naya Y, Ukimura O, Watanabe H. Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight. J Urol. 1997;157(2):476–9.

    Article  CAS  PubMed  Google Scholar 

  164. Presicce F, De Nunzio C, Gacci M, Finazzi Agrò E, Tubaro A. Non-invasive ultrasound measurements in male patients with LUTS and benign prostatic obstruction: implication for diagnosis and treatment. Minerva Urol Nefrol. 2017;69(3):220–33.

    PubMed  Google Scholar 

  165. Li HZ, Zhang XB, Li JC, Xiao H, Huang ZM. Study on the change of bladder wall weight pre and after surgery in patients with benign prostatic hyperplasia. Zhonghua Wai Ke Za Zhi. 2007;45(14):954–6.

    PubMed  Google Scholar 

  166. Miyashita H, Kojima M, Miki T. Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Ultrasound Med Biol. 2002;28(8):985–90.

    Article  PubMed  Google Scholar 

  167. Ho CCK, Ngoo KS, Hamzaini AH, Rizal AMM, Zulkifli MZ. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia. Clin Ter. 2014;165(2):75–81.

    CAS  PubMed  Google Scholar 

  168. Greene DR, Egawa S, Hellerstein DK, Scardino PT. Sonographic measurements of transition zone of prostate in men with and without benign prostatc hyperplasia. Urology. 1990;36(4):293–9.

    Article  CAS  PubMed  Google Scholar 

  169. Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol. 1995;154(5):1764–9.

    Article  CAS  PubMed  Google Scholar 

  170. Qalawena MM, Al-Shatouri MA, Motawaa MA, El-Sakka AI. Association between prostate zonal volume and erectile dysfunction in patients with benign prostatic hyperplasia. Sex Med. 2020;8(2):205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  171. Tian Y, Liu HM, Yang B, Yang XS, Sun ZL, Sun F, et al. Prostatic anatomical parameters correlate with clinical characteristics suggestive of benign prostatic hyperplasia. Asian J Androl. 2021;23(1):64–8.

    Article  PubMed  Google Scholar 

  172. Lepor H, Nieder A, Feser J, O’Connell C, Dixon C. Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia. J Urol. 1997;158(1):85–8.

    Article  CAS  PubMed  Google Scholar 

  173. • Kurokawa S, Kamei J, Sakata K, Sugihara T, Fujisaki A, Ando S, et al. The cutoff value of transitional zone index predicting the efficacy of dutasteride on subjective symptoms in patients with benign prostate hyperplasia. LUTS. 2022;14(4):261–6. This study provides us with data about different parameters (especially TZI) that can predict the outcome of pharmacological treatment.

    Article  CAS  PubMed  Google Scholar 

  174. Choi JD, Kim JH, Ahn SH. Transitional zone index as a predictor of the efficacy of α-blocker and 5α-reductase inhibitor combination therapy in Korean patients with benign prostatic hyperplasia. Urol Int. 2016;96(4):406–12.

    Article  CAS  PubMed  Google Scholar 

  175. Ohtani T, Hayashi Y, Kishino TE, Fujimoto K, Hirao Y, Ozono S, et al. A new parameter in decision making for transurethral electroresection of benign prostate hyperplasia. Eur Urol. 1999;35(3):185–91.

    Article  CAS  PubMed  Google Scholar 

  176. Kojima M, Ochiai A, Naya Y, Okihara K, Ukimura O, Miki T. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction. Eur Urol. 2000;37(4):436–42.

    Article  CAS  PubMed  Google Scholar 

  177. Aldaqadossi HA, Elgamal SA, Saad M. The value of measuring the prostatic resistive index vs. pressure-flow studies in the diagnosis of bladder outlet obstruction caused by benign prostatic hyperplasia. Arab J Urol. 2012;10(2):186–91.

    Article  PubMed  PubMed Central  Google Scholar 

  178. Belenky A, Abarbanel Y, Cohen M, Yossepowitch O, Livne PM, Bachar GN. Detrusor resistive index evaluated by Doppler ultrasonography as a potential indicator of bladder outlet obstruction. Urology. 2003;62(4):647–50.

    Article  CAS  PubMed  Google Scholar 

  179. Suzuki T, Otsuka A, Ozono S. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Int J Urol. 2016;23(11):929–33.

    Article  CAS  PubMed  Google Scholar 

  180. Tsuru N, Kurita Y, Masuda H, Suzuki K, Fujita K. Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy. Int J Urol. 2002;9(8):427–30.

    Article  PubMed  Google Scholar 

  181. Kwon SY, Ryu JW, Choi DH, Lee KS. Clinical significance of the resistive index of prostatic blood flow according to prostate size in benign prostatic hyperplasia. Int Neurourol J. 2016;20(1):75–80.

    Article  PubMed  PubMed Central  Google Scholar 

  182. Berger AP, Bartsch G, Deibl M, Alber H, Pachinger O, Fritsche G, et al. Atherosclerosis as a risk factor for benign prostatic hyperplasia. BJU Int. 2006;98(5):1038–42.

    Article  PubMed  Google Scholar 

  183. Ku JH, Ko DW, Cho JY, Oh SJ. Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms. Urology. 2010;75(6):1467–71.

    Article  PubMed  Google Scholar 

  184. • Kim BH, Kim KH, Ko YH, Song PH, Kim TH, Kim BS. The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study. Prostate Int. 2016;4(1):30–5. This study provides us data about different parameters (especially prostatic urethral angle) that can predict the outcome of pharmacological treatment.

    Article  PubMed  PubMed Central  Google Scholar 

  185. Farag FF, Meletiadis J, Saleem MD, Feitz WF, Heesakkers JP. Near-infrared spectroscopy of the urinary bladder during voiding in men with lower urinary tract symptoms: a preliminary study. Biomed Res Int. 2013;2013: 452857.

    Article  PubMed  PubMed Central  Google Scholar 

  186. Macnab AJ, Stothers L. Development of a near-infrared spectroscopy instrument for applications in urology. Can J Urol. 2008;15(5):4233–40.

    PubMed  Google Scholar 

  187. Stothers L, Guevara R, Macnab A. Classification of male lower urinary tract symptoms using mathematical modelling and a regression tree algorithm of noninvasive near-infrared spectroscopy parameters. Eur Urol. 2010;57(2):327–33.

    Article  PubMed  Google Scholar 

  188. Yurt M, Süer E, Gülpınar Ö, Telli O, Arıkan N. Diagnosis of bladder outlet obstruction in men with lower urinary tract symptoms: comparison of near infrared spectroscopy algorithm and pressure flow study in a prospective study. Urology. 2012;80(1):182–6.

    Article  PubMed  Google Scholar 

  189. Zhang P, Yang Y, Wu ZJ, Zhang CH, Zhang XD. Diagnosis of bladder outlet obstruction in men using a near-infrared spectroscopy instrument as the noninvasive monitor for bladder function. Urology. 2013;82(5):1098–102.

    Article  PubMed  Google Scholar 

  190. Chung DE, Lee RK, Kaplan SA, Te AE. Concordance of near infrared spectroscopy with pressure flow studies in men with lower urinary tract symptoms. J Urol. 2010;184(6):2434–9.

    Article  PubMed  Google Scholar 

  191. McRae LP, Bottaccini MR, Gleason DM. Noninvasive quantitative method for measuring isovolumetric bladder pressure and urethral resistance in the male: I. Experimental validation of the theory. Neurourol Urodyn. 1995;14(2):101–14.

    Article  CAS  PubMed  Google Scholar 

  192. Drinnan MJ, McIntosh SL, Robson WA, Pickard RS, Ramsden PD, Griffiths CJ. Inter-observer agreement in the estimation of bladder pressure using a penile cuff. Neurourol Urodyn. 2003;22(4):296–300.

    Article  PubMed  Google Scholar 

  193. Griffiths CJ, Harding C, Blake C, McIntosh S, Drinnan MJ, Robson WA, et al. A nomogram to classify men with lower urinary tract symptoms using urine flow and noninvasive measurement of bladder pressure. J Urol. 2005;174(4):1323–6 (discussion 1326; author reply 1326).

    Article  CAS  PubMed  Google Scholar 

  194. Bianchi D, Di Santo A, Gaziev G, Miano R, Musco S, Vespasiani G, et al. Correlation between penile cuff test and pressure-flow study in patients candidates for trans-urethral resection of prostate. BMC Urol. 2014;14(1):103.

    Article  PubMed  PubMed Central  Google Scholar 

  195. Borrini L, Lukacs B, Ciofu C, Gaibisso B, Haab F, Amarenco G. Predictive value of the penile cuff-test for the assessment of bladder outlet obstruction in men. Prog Urol. 2012;22(11):657–64.

    Article  CAS  PubMed  Google Scholar 

  196. Parsons BA, Bright E, Shaban AM, Whitehouse A, Drake MJ. The role of invasive and non-invasive urodynamics in male voiding lower urinary tract symptoms. World J Urol. 2011;29(2):191–7.

    Article  PubMed  Google Scholar 

  197. • Ganpule AP, Batra RS, Shete NB, Singh AG, Sabnis RB, Desai MR. BPH nomogram using IPSS, prostate volume, peak flow rate, PSA and median lobe protrusion for predicting the need for intervention: development and internal validation. Am J Clin Exp Urol. 2021;9(3):202–10. This study provides us data about nomogram made of different parameters that can predict the need for surgical intervention.

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was not supported by any fund.

Author information

Authors and Affiliations

  1. Hebrew University of Jerusalem, Jerusalem, Israel

    Rei Ben Muvhar

  2. Department of Urology, Soroka University Medical Center, Yitzhak Rager Blv., P.O. Box: 151, Be’er Sheva, Israel

    Jonathan Wagmaister & Matan Mekayten

  3. Ben-Gurion University of the Negev, Be’er Sheva, Israel

    Matan Mekayten

Authors
  1. Rei Ben Muvhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan Wagmaister
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matan Mekayten
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RBM: Literature review, Manuscript writing/editing YW: Manuscript revising and editing, quality control MM: Protocol/project development, Manuscript writing/editing, Supervising project.

Corresponding author

Correspondence to Matan Mekayten.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics Approval

This article does not contain any studies with human or animal subjects performed by any of the authors and therefore required no inform consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 18 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ben Muvhar, R., Wagmaister, J. & Mekayten, M. Navigating the Diagnostic Maze: Unraveling the Non-invasive Evaluation of Bladder Outlet Obstruction in Men—a Comprehensive Systematic Review. Curr Bladder Dysfunct Rep 18, 318–332 (2023). https://doi.org/10.1007/s11884-023-00717-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-023-00717-3

Keywords

Search

Navigation